[Risk assessment in patients undergoing osseous antiresorptive therapy in dentistry. An update]. [electronic resource]
Producer: 20140305Description: 985-1001; 955 p. digitalISSN:- 0256-2855
- Aged
- Alendronate -- adverse effects
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- etiology
- Bone Density Conservation Agents -- administration & dosage
- Bone Neoplasms -- drug therapy
- Bone Resorption -- drug therapy
- Contraindications
- Dental Implants
- Diphosphonates -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Male
- Multiple Myeloma -- drug therapy
- Osteoporosis -- drug therapy
- Peri-Implantitis -- etiology
- Risk Assessment
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.